Sign In
Buy CR
$215.85
-3.22 (-1.47%)
At Close: Jul 13, 2026
Crane NXT Announces Dates for Second Quarter 2026 Earnings Release and Earnings Call
04:05pm, Thursday, 09'th Jul 2026
WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a global leader in authentication and traceability technologies, today announced its schedule for the company's second qua
Crane Company Announces Date for Second Quarter 2026 Earnings Release and Teleconference
08:30am, Monday, 29'th Jun 2026
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) announces the following schedule and teleconference information for its second quarter 2026 earnings release: Earnings Release: July 28, 2026
Headwater Gold Announces Commencement of Centerra-Funded Drilling at Crane Creek Project, Idaho
06:30am, Monday, 29'th Jun 2026
Vancouver, British Columbia – TheNewswire - June 29, 2026: Headwater Gold Inc. (CSE: HWG) (OTCQX: HWAUF) (the “Company” or “Headwater”) is pleased to announce that Centerra Gold Inc. (“Cen
BRIXMOR PROPERTY GROUP ISSUES ANNUAL CORPORATE RESPONSIBILITY REPORT
07:55am, Thursday, 18'th Jun 2026
NEW YORK, June 18, 2026 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) ("Brixmor" or the "Company") announced today the release of its eighth annual Corporate Responsibility (CR) Report, whi
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
10:00am, Monday, 15'th Jun 2026
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-viral genetic medicines company today announced its financial
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously
Implied Volatility Surging for Crane Company Stock Options
12:41pm, Wednesday, 27'th May 2026
Investors need to pay close attention to CR stock based on the movements in the options market lately.
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement wit
Crane Co (CR) Stock Down 4.1% -- Now Undervalued? GF Score: 86/100
08:58pm, Friday, 15'th May 2026
On May 15, 2026, Crane Co (CR) shares fell 4.1% to a current price of $172.19. This decline comes in the context of a 52-week range that saw a high of $214.31 a
Crane NXT Q1 Earnings Call Highlights
09:06pm, Saturday, 09'th May 2026
Crane NXT NYSE: CXT reported first-quarter 2026 sales growth and reaffirmed its earnings outlook while updating its full-year guidance to include the recently completed acquisition of Antares Vision.
Crane NXT Reports First Quarter 2026 Results
04:05pm, Wednesday, 06'th May 2026
Completes Acquisition of Antares Vision, a Global Leader in Inspection, Detection, and Track & Trace Technologies Delivers Organic Sales Growth of 6%; Maintains Full Year EPS Guidance of $4.10 to $4.4
Crane Co (CR) Stock Down 3.1% -- Now Undervalued? GF Score: 87/100
05:21pm, Friday, 01'st May 2026
On May 01, 2026, Crane Co (CR) shares fell 3.1% to $172.24. This decline comes amid a 52-week trading range of $159.58 to $214.31, indicating some volatility in
Crane Company (CR) Q1 2026 Earnings Call Transcript
03:21pm, Tuesday, 28'th Apr 2026
Crane Company (CR) Q1 2026 Earnings Call Transcript
Crane Company Reports First Quarter 2026 Results and Raises Full Year EPS Guidance
04:15pm, Monday, 27'th Apr 2026
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company ("Crane," NYSE:CR) today announced its financial results for the first quarter of 2026 and raised its full year adjusted EPS outlook. Alex Alcala, Crane
Crane Company Announces Completion of CEO Succession
08:30am, Monday, 27'th Apr 2026
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) today announced the completion of its previously disclosed CEO succession plan, effective April 27, 2026. Mr. Alex Alcala has assumed the rol
